EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial

Yong Min Lee iD, Bobak Bahrami, Duleepa Baranage, Premala Devi Sivagurunathan, Wilson Wong, Montserrat Maria Bausili, Surbhi Agrawal, Jagjit Singh Gilhotra iD, Shane Durkin, David Sia, Dinesh Selva, Stewart Lake iD und 2 weitere

Clinical & Experimental Ophthalmology · 2024

DOI: 10.1111/ceo.14432 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical & Experimental Ophthalmology, 2024. Verfasst von Yong Min Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Retinal Perforations, Visual Acuity, Thiophenes, Carbonic Anhydrase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Adelaide.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess topical dorzolamide as medical therapy for idiopathic full‐thickness macular holes (FTMHs).

Methods

Randomised, double‐blinded, placebo‐controlled, single‐centre clinical trial involving 32 patients with idiopathic small FTMHs (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal PerforationsVisual AcuityThiophenesCarbonic Anhydrase InhibitorsSulfonamidesOphthalmic SolutionsTomography, Optical CoherenceHumansDouble-Blind MethodMaleFemaleAgedMiddle AgedTreatment OutcomeVitrectomyAdministration, TopicalFollow-Up StudiesEndotamponade

Stichwörter der Autor:innen

clinical trialmacular holeplacebotopical dorzolamide

Substanzen

dorzolamideThiophenesCarbonic Anhydrase InhibitorsSulfonamidesOphthalmic Solutions

Autor:innen und Institutionen

  • Ophthalmology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • The University of Adelaide, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia.
  • Ophthalmology Department, OasisEye Specialists, Kuala Lumpur, Malaysia.
  • Ophthalmology Department, Flinders Medical Centre, Adelaide, South Australia, Australia.
  • Machine Learning Division, Ophthalmic Research Laboratory, University of Adelaide, Adelaide, South Australia, Australia.

ORCID-Profile: Yong Min Lee, Jagjit Singh Gilhotra, Stewart Lake, Robert J Casson, Weng Onn Chan

Förderung

  • University of Adelaide

Zitieren

APA

Lee, Y. M., Bahrami, B., Baranage, D., Sivagurunathan, P. D., Wong, W., Bausili, M. M., Agrawal, S., Gilhotra, J. S., Durkin, S., Sia, D., Selva, D., Lake, S., Casson, R. J., & Chan, W. O. (2024). Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14432

Vancouver

Lee YM, Bahrami B, Baranage D, Sivagurunathan PD, Wong W, Bausili MM, et al. Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial. Clinical & Experimental Ophthalmology. 2024. doi:10.1111/ceo.14432

BibTeX
@article{Lee2024,
  author = {Lee, Yong Min and Bahrami, Bobak and Baranage, Duleepa and Sivagurunathan, Premala Devi and Wong, Wilson and Bausili, Montserrat Maria and Agrawal, Surbhi and Gilhotra, Jagjit Singh and Durkin, Shane and Sia, David and Selva, Dinesh and Lake, Stewart and Casson, Robert J and Chan, Weng Onn},
  title = {Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2024},
  doi = {10.1111/ceo.14432}
}
Kostenlos starten →